Website Only Discount!
Register now and save $100 off the Current In-Person Registration Fee!
Please Mention Promo Code WEB at the time of Registration.
OPTIMIZE LIFECYCLE MANAGEMENT FROM PRECLINICAL DEVELOPMENT THROUGH POST-PRODUCT LAUNCH TO IMPROVE EARLY STAGE PRODUCT PLANNING AND ENSURE SUCCESSFUL COMMERCIALIZATION OF NEW DRUGS
World Congress’ Bio/Pharma New Product Planning Summit is designed to bring manufacturers from market access, commercial, market research, product launch, research and development, marketing, and new product planning teams together to discuss key strategies to develop an effective new product plan to ensure the successful commercialization of new drugs. Attendees will walk away with key strategies to establish an effective new product plan to ensure effective early stage decision making, lifecycle management, and successful launch of new drugs to the market.
- Gain Insight into effective strategies for developing a new product plan from preclinical to post launch of a new drug
- Assess the evolving stakeholder landscape and prepare market access strategies early on in the drug development process
- Improve life cycle management to develop product plans for multiple indications
- Overcome barriers in the product development process
The PDF brochure for the Lifesciences New Product Planning and Launch Strategies Summit is now available. Download it now
Distinguished Speaker Faculty Includes:
ATTENDEES
SPEAKERS
SESSIONS
HOURS
Don't just take our word for it!
Outstanding and highly relevant content with excellent speakers
–-- Patient Experience Lead, UCB, Inc. Attending Companies
The evolving healthcare system requires everyone to break down silos and build more integrated solutions. World Congress’ Integrate meetings bring together crucial yet complementary functions: specialty network design, supply chain strategy, patient services and hubs, and compliance. It’s a wonderful opportunity for the industry to reflect on how we can all serve patients more effectively and efficiently. I expect this multi-faceted event to trigger many new crossfunctional conversations and collaborations.
–-- Adam J. Fein, Ph.D., President, Pembroke Consulting, Inc.; Author, Drug Channels
Very interactive, high-level discussions and relevant agenda topics made this Congress valuable time spent
–-- Director, Advocacy and Alliance Development, GSK